Skip to main content

Table 1 Targeted high-risk MDRO screening among public and private hospitals in Switzerland

From: Nation-wide survey of screening practices to detect carriers of multi-drug resistant organisms upon admission to Swiss healthcare institutions

 

ESBL

CPE

MDR-Acinetobacter

MDR-Pseudomonas

VRE

MRSA

Targeted screening (%)

 Public (n = 102)a:

  Institutional:

82 (89%)

77 (83%)

37 (40%)

36 (39%)

38 (41%)

93 (100%)

  Only in certain units:

0

0

1 (1%)

2 (2%)

4 (4%)

0

  None:

10 (11%)

16 (17%)

55 (59%)

55 (59%)

51 (55%)

0

 Private (n = 78)b:

  Institutional:

36 (67%)

38 (70%)

23 (43%)

18 (33%)

27 (50%)

52 (95%)

  Only in certain units:

4 (7%)

4 (8%)

2 (4%)

8 (15%)

3 (6%)

3 (5%)

  None:

14 (26%)

12 (22%)

28 (53%)

28 (52%)

24 (44%)

0

  1. Abbreviations: ESBL extended-spectrum beta-lactamase, CPE carbapenemase-producing enterobacteriaceae, MDR multi-drug resistant, VRE vancomycin-resistant enterococcus, MRSA methicillin resistant Staphylococcus aureus
  2. aMissing values for: ESBL = 10, CPE = 9, Acinetobacter baumanii = 9, Pseudomonas aeruginosa = 9, VRE = 9 and MRSA = 9
  3. bMissing values for: ESBL = 24, CPE = 24, Acinetobacter baumanii = 25, Pseudomonas aeruginosa = 24, VRE = 24 and MRSA = 23